27754781|t|Quantification of leakage of sub-micron aerosols through surgical masks and facemasks for pediatric use
27754781|a|Surgical respirators, surgical masks (SMs), and facemasks for pediatric use (FPUs) are routinely used in the U.S. healthcare industry as personal protective equipment (PPE) against infectious diseases. While N95s including surgical respirators have been routinely studied, SMs and FPUs have not received as much attention, particularly in the context of aerosolized threats. This is because SMs and PFUs are not designed to protect against sub-micron aerosols. However, with the possibility of new or re-emerging airborne diseases or bio-aerosol weapons lingering, combined with the limited availability of respirators and logistical issues associated with fit-testing millions, the general adult and pediatric populations may elect to wear SMs and FPUs, respectively, in the case of a pandemic or a bio-terrorist attack. When a person dons a PPE, gaps are created between the wearer's face and the PPE, and aerosols leaking through these gaps can be an important contributor to the risk of infection compared to filtered aerosols. To understand and quantify the contribution of leakage of aerosols through gaps, with particular emphasis on SMs and FPUs, this study investigated leakage of charge-neutralized, polydispersed, dried sodium-chloride aerosols across different brands of PPE. Different breathing rates, aerosol particle sizes, and gap sizes were considered. A few major findings of this study were: (a) leakage, is not a strong function of sub-micron aerosol size; (b) for the same gap size, leakage of aerosols through surgical respirators can often be higher than in SMs and FPUs; and (c) as the gap size increases, the increase in leakage through surgical respirators is higher compared for SMs and FPUs, implying that some SMs and FPUs that possess electret layers may be preferable to N95s that have not been fit-tested. The results obtained can also be used to explain conflicting findings from clinical studies on the effectiveness of SMs when compared to N95s and can be input into risk-assessment models to determine the increase in infection rate resulting from deployment of PPE under less-than-ideal conditions.
27754781	0	14	Quantification	T081	C1709793
27754781	18	25	leakage	T033	C4281748
27754781	29	39	sub-micron	T081	C0392762
27754781	40	48	aerosols	T073	C0001712
27754781	49	56	through	T169	C0332273
27754781	57	71	surgical masks	T074	C0181758
27754781	76	85	facemasks	T074	C0024861
27754781	90	99	pediatric	T080	C1521725
27754781	100	103	use	T169	C0457083
27754781	104	124	Surgical respirators	T074	C0677448
27754781	126	140	surgical masks	T074	C0181758
27754781	142	145	SMs	T074	C0181758
27754781	152	161	facemasks	T074	C0024861
27754781	166	175	pediatric	T080	C1521725
27754781	181	185	FPUs	T074	C0024861
27754781	213	216	U.S	T083	C0041703
27754781	218	237	healthcare industry	T093	C0525051
27754781	241	270	personal protective equipment	T073	C1443871
27754781	272	275	PPE	T073	C1443871
27754781	277	284	against	T080	C0521124
27754781	285	304	infectious diseases	T047	C0009450
27754781	312	316	N95s	T061	C2922048
27754781	317	326	including	T169	C0332257
27754781	327	347	surgical respirators	T074	C0677448
27754781	377	380	SMs	T074	C0181758
27754781	385	389	FPUs	T074	C0024861
27754781	395	407	not received	T033	C3845783
27754781	416	425	attention	T041	C0004268
27754781	447	454	context	T078	C0449255
27754781	458	469	aerosolized	T073	C0001712
27754781	470	477	threats	T078	C0749385
27754781	495	498	SMs	T074	C0181758
27754781	503	507	PFUs	T074	C0024861
27754781	528	535	protect	T169	C1553199
27754781	536	543	against	T080	C0521124
27754781	544	554	sub-micron	T081	C0392762
27754781	555	563	aerosols	T073	C0001712
27754781	617	625	airborne	T169	C3242389
27754781	626	634	diseases	T047	C0012634
27754781	638	667	bio-aerosol weapons lingering	T037	C0481107
27754781	669	677	combined	T080	C0205195
27754781	687	694	limited	T169	C0439801
27754781	695	710	availability of	T169	C0470187
27754781	711	722	respirators	T074	C0087153
27754781	745	760	associated with	T080	C0332281
27754781	761	772	fit-testing	T057	C0337137
27754781	795	800	adult	T100	C0001675
27754781	805	814	pediatric	T080	C1521725
27754781	815	826	populations	T098	C1257890
27754781	831	844	elect to wear	T033	C0243095
27754781	845	848	SMs	T074	C0181758
27754781	853	857	FPUs	T074	C0024861
27754781	890	898	pandemic	T067	C1615608
27754781	904	924	bio-terrorist attack	T051	C1443843
27754781	933	939	person	T098	C0027361
27754781	947	950	PPE	T073	C1443871
27754781	952	956	gaps	T082	C3887622
27754781	981	994	wearer's face	T029	C0015450
27754781	1003	1006	PPE	T073	C1443871
27754781	1012	1020	aerosols	T073	C0001712
27754781	1021	1028	leaking	T169	C0332234
27754781	1029	1036	through	T169	C0332273
27754781	1043	1047	gaps	T082	C3887622
27754781	1087	1104	risk of infection	T033	C0582147
27754781	1105	1113	compared	T052	C1707455
27754781	1117	1125	filtered	T068	C0016107
27754781	1126	1134	aerosols	T073	C0001712
27754781	1154	1162	quantify	T081	C1709793
27754781	1167	1179	contribution	T052	C1880177
27754781	1183	1190	leakage	T033	C4281748
27754781	1194	1202	aerosols	T073	C0001712
27754781	1203	1210	through	T169	C0332273
27754781	1211	1215	gaps	T082	C3887622
27754781	1245	1248	SMs	T074	C0181758
27754781	1253	1257	FPUs	T074	C0024861
27754781	1270	1282	investigated	T169	C1292732
27754781	1283	1290	leakage	T033	C4281748
27754781	1294	1312	charge-neutralized	T067	C2825492
27754781	1314	1327	polydispersed	T077	C3641149
27754781	1329	1334	dried	T080	C1512080
27754781	1335	1350	sodium-chloride	T121,T123,T197	C0037494
27754781	1351	1359	aerosols	T073	C0001712
27754781	1367	1376	different	T080	C1705242
27754781	1377	1383	brands	T170	C0592503
27754781	1387	1390	PPE	T073	C1443871
27754781	1392	1401	Different	T080	C1705242
27754781	1402	1417	breathing rates	T201	C0231832
27754781	1419	1426	aerosol	T073	C0001712
27754781	1427	1441	particle sizes	T081	C0030608
27754781	1447	1456	gap sizes	T082	C0456389
27754781	1480	1485	major	T080	C0205164
27754781	1486	1494	findings	T169	C2607943
27754781	1519	1526	leakage	T033	C4281748
27754781	1537	1543	strong	T080	C0442821
27754781	1544	1552	function	T169	C0542341
27754781	1556	1566	sub-micron	T081	C0392762
27754781	1567	1574	aerosol	T073	C0001712
27754781	1575	1579	size	T082	C0456389
27754781	1598	1606	gap size	T082	C0456389
27754781	1608	1615	leakage	T033	C4281748
27754781	1619	1627	aerosols	T073	C0001712
27754781	1628	1635	through	T169	C0332273
27754781	1636	1656	surgical respirators	T074	C0677448
27754781	1670	1676	higher	T080	C0205250
27754781	1685	1688	SMs	T074	C0181758
27754781	1693	1697	FPUs	T074	C0024861
27754781	1714	1722	gap size	T082	C0456389
27754781	1723	1732	increases	T169	C0442805
27754781	1738	1746	increase	T169	C0442805
27754781	1750	1757	leakage	T033	C4281748
27754781	1758	1765	through	T169	C0332273
27754781	1766	1786	surgical respirators	T074	C0677448
27754781	1797	1805	compared	T052	C1707455
27754781	1810	1813	SMs	T074	C0181758
27754781	1818	1822	FPUs	T074	C0024861
27754781	1843	1846	SMs	T074	C0181758
27754781	1851	1855	FPUs	T074	C0024861
27754781	1861	1868	possess	T078	C3154893
27754781	1869	1884	electret layers	T080	C0205556
27754781	1906	1910	N95s	T061	C2922048
27754781	1930	1940	fit-tested	T057	C0337137
27754781	2017	2033	clinical studies	T062	C0008972
27754781	2041	2054	effectiveness	T080	C1280519
27754781	2058	2061	SMs	T074	C0181758
27754781	2067	2075	compared	T052	C1707455
27754781	2079	2083	N95s	T061	C2922048
27754781	2106	2128	risk-assessment models	T170	C0282574
27754781	2146	2154	increase	T169	C0442805
27754781	2158	2167	infection	T046	C3714514
27754781	2168	2172	rate	T081	C1521828
27754781	2202	2205	PPE	T073	C1443871